Why is ASX chemicals company Incitec Pivot Ltd (ASX: IPL) up over 6%?

March 21, 2023 12:25 PM AEDT | By Priyabrata Prusty
Follow us on Google News:

Highlight:

  • Incitec Pivot Ltd. shares surged as much as 6.7% in opening trade to an intraday high of AU$3.330.
  • On Monday, 20 March 2023, post market hours, the company announced entering into an agreement to sell its ammonia production facility in Waggaman.
  • Incitec Pivot Ltd has signed a 25-year ammonia supply agreement as part of the deal.

Shares of Australian multinational chemicals company Incitec Pivot Ltd (ASX: IPL) surged as much as 6.7% in opening trade, outperforming the broader S&P/ASX 200 index, which was up 1.12%. As of 11:15 am, AEDT, IPL shares were up 3% at AU$3.220 after the company announced entering into an agreement with CF Industries Holdings, Inc. (NYSE: CF) for the sale of its ammonia production facility located in Waggaman, Louisiana, for a total consideration of US$1.675 billion or AU$2.50 billion.

The announcement made post-market hours on Monday, said that as part of the deal, Incitec Pivot Ltd has signed a 25-year ammonia supply agreement with CF to supply up to 200k short tonnes of ammonia per annum to its Dyno Nobel Americas (DNA) explosives business. Also, this ammonia supply will be done at producer cost for DNA. The value assigned to this supply agreement is nearly US$425 million or AU$634 million, which will be deducted from the total amount to be paid to IPL for the sale of Waggaman.

Financial details of the transaction 

IPL will realise a value of AU$1,884 million for Waggaman divestment after deducting a tax component of AU$616 million from the gross proceeds of AU$2.5 billion. The value assigned to the long-term ammonia offtake agreement is AU$634 million. So, the net cash proceeds that IPL will receive from the proposed deal will be AU$1,249 million.

The company intends to allocate the cash proceeds from the proposed deal in line with its capital allocation framework.

Commenting on the deal, IPL's managing director and CEO, Jenne Johns said:

ASX IPL

The proposed deal is subject to US anti-trust regulatory clearance and the completion of other customary closing conditions. 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.



We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK